Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production

Lactobacillus casei strain Shirota was selected as a bacterial carrier for the development of live mucosal vaccines against coronavirus. A 75 kDa fragment of transmissible gastroenteritis coronavirus (TGEV) spike glycoprotein S was used as the model coronavirus antigen. The S glycoprotein was cloned...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, P.S., Kwang, J., Lee, Y.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115493/
https://www.ncbi.nlm.nih.gov/pubmed/15661381
http://dx.doi.org/10.1016/j.vaccine.2004.09.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115493/
https://www.ncbi.nlm.nih.gov/pubmed/15661381
http://dx.doi.org/10.1016/j.vaccine.2004.09.015

Ejemplares similares